Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Hematological Oncology|June 9, 2021
Langerhans cell histiocytosis: Version 2021Nitya Gulati, Carl E Allen
Hematology/Oncology Clinics of North America|March 25, 2025
Genomic Alterations in Langerhans Cell HistiocytosisNitya Gulati, Erin Peckham-Gregory, D Williams Parsons, et al.
Hematology. American Society of Hematology. Education Program|December 5, 2025
Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessmentOlive S Eckstein, Nitya Gulati
Leukemia & Lymphoma|February 24, 2018
Enhancer of zeste homolog 2 (EZH2) inhibitorsNitya Gulati, Wendy Béguelin, Lisa Giulino-Roth
Blood|February 28, 2020
Langerhans cell histiocytosisCarlos Rodriguez-Galindo, Carl E Allen
Drugs of Today (Barcelona, Spain : 1998)|October 18, 2007
Langerhans cell histiocytosis: a review of past, current and future therapiesCarl E Allen, Kenneth L McClain
Hematology. American Society of Hematology. Education Program|December 6, 2015
Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disordersCarl E Allen, D Williams Parsons
Hematology. American Society of Hematology. Education Program|December 6, 2015
Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosisCarl E Allen, Kenneth L McClain
The American Journal of Dermatopathology|September 29, 2025
Unicentric Subcutaneous Hyaline Vascular Castleman Disease With Concurrent Features of Calcifying Fibrous TumorPetro Vavrukh, Rohan Katti, Nitya Gulati, et al.
British Journal of Haematology|March 19, 2024
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosisVivekanudeep Karri, Howard Lin, Jessica Velazquez, et al.
Pageof 14